News | April 16, 2014

Covidien Implements Voluntary Recall of its Pipeline Embolization Device and Alligator Retrieval Device

April 16, 2014 — Covidien announced it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline embolization device and Alligator retrieval device, where the polytetrafluoroethylene (PTFE) coating applied to the delivery wire could delaminate and detach from the devices.

PTFE coating is used to reduce friction between devices and ease navigation through the vasculature. Delamination of the PTFE coating could potentially lead to embolic occlusion in the cerebral vasculature with the risk of stroke and/or death.

Covidien learned of this issue through internal product testing. The company has not received any reports of patient injuries to date related to this issue.

The Pipeline embolization device is indicated for the endovascular treatment of adults (22 years of age and older) with large or giant wide?necked intracranial aneurysms in the internal carotid artery from the petrous to the superior hypophyseal segments. The Alligator retrieval device is intended for use in the peripheral and neuro?vasculature for foreign body retrieval.

A total of 32 Pipeline embolization devices and 621 Alligator retrieval devices are affected by this recall. The products were manufactured and distributed from May 2013 to March 2014. This issue involves both the Pipeline embolization device sold in the United States, Australia, France, Germany and United Kingdom, and the Alligator retrieval device sold in the United States, Australia, Canada, Europe and Latin America.

Covidien alerted customers to the recall by letter on April 1, 2014, and is arranging for replacement of the recalled products. The U.S. Food and Drug Administration (FDA) and other regulatory bodies also have been notified.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

For more information: www.covidien.com

Related Content

News | Stroke

July 26, 2022 — The American Heart Association, the world’s leading nonprofit organization focused on heart and brain ...

Home July 26, 2022
Home
News | Stroke

July 26, 2022 — While overall current electronic cigarette use (meaning use within the past 30 days) fell slightly in ...

Home July 26, 2022
Home
News | Stroke

July 6, 2022 — In one of the first studies to investigate the overall quality of care and outcomes of stroke care for ...

Home July 06, 2022
Home
News | Stroke

July 5, 2022 — Is lowering patients' blood pressure following treatment for an ischemic stroke a safe way to lead to ...

Home July 05, 2022
Home
News | Stroke

July 1, 2022 — The carotid artery in 81-year-old Reynold Zamora’s neck was nearly completely blocked with plaque ...

Home July 01, 2022
Home
News | Stroke

June 30, 2022 — All five hospitals of Henry Ford Health, which are equipped to treat stroke, earned Get with the ...

Home June 30, 2022
Home
News | Stroke

June 20, 2022 — Clinical trials of new gel treatments for stroke should be delayed until technology used in the tests is ...

Home June 20, 2022
Home
News | Stroke

June 14, 2022 — A new American Heart Association scientific statement highlights the need for more data and research ...

Home June 14, 2022
Home
News | Stroke

May 18, 2022 — Continuous monitoring with an insertable cardiac monitor (ICM) is shown to be more successful in ...

Home May 18, 2022
Home
News | Stroke

May 5, 2022 – Survivors of serious stroke can reduce their chances of dying within the year by 76% if they complete a ...

Home May 05, 2022
Home
Subscribe Now